ArticleThe Journal of dermatology2026

Efficacy of Upadacitinib in a Middle-Aged Man With Netherton Syndrome Refractory to Dupilumab: A Case Report.

Bo-Jie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.